Latest filing published 08 Feb 2022 for Biodelivery Sciences International INC, €58k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
James Vollins discloses dealings in Biodelivery Sciences International Inc to SEC (Form 4). The record holds 2 filings, for trades running from 27 January 2022 to 4 February 2022.
Sales make up the whole of the open-market record (1 sale, €58k). The rest of the record consists of 1 option exercise.
The latest filing, published on 8 February 2022, reports an open-market sale of €58k in Biodelivery Sciences International Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations